This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Scolapio, J. S. Search for Related Content PubMed PubMed Citation Articles by Scolapio, J. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Carbohydrates Dietary Fats Social Bookmarking                         What's this?

Effect of Growth Hormone, Glutamine, and Diet on Body Composition in Short Bowel Syndrome: A Randomized, Controlled Study

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida

Background: A previous controlled study of ten patients with short bowel syndrome (SBS) reported human recombinant growth hormone resulted in a significant increase in body weight and lean body mass (LBM) without clinical edema. The aim of this study was to assess the effect of growth hormone, glutamine, and diet on body composition. Methods: A randomized, 6-week, double-blind, placebo-controlled, crossover study was performed in eight patients. Active treatment was 21 days of growth hormone, oral glutamine, and a high-carbohydrate-low-fat (HCLF) diet. Body composition was determined by dual-energy x-ray absorptiometry (DEXA) scan. Treatments were compared by paired t test. Results: Active treatment resulted in significant increases in body weight (mean 3.02 ± 0.7 kg, p < .05) and lean body mass, (mean 3.96 ± 0.5 kg, p < .001). Percent body fat was significantly reduced in the actively treated group (mean -2.51% ± 0.4, p < .001). Body weight returned to baseline within 2 weeks of discontinuing active treatment. Macronutrient and fluid absorption did not increase with active treatment. Conclusions: Treatment with growth hormone, glutamine, and HCLF diet resulted in decreased percent body fat and increased body weight and LBM in patients with SBS, without an increase in macronutrient or fluid absorption. The positive findings are most likely a reflection of increased extracellular fluid because all eight patients developed peripheral edema on active treatment. Furthermore, the positive effect of active treatment does not appear to be sustained once discontinued. (Journal of Parenteral and Enteral Nutrition 23:309-313, 1999)

Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 6, 309-313 (1999)
DOI: 10.1177/0148607199023006309


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. A. Ching, K. Gura, B. Modi, and T. Jaksic Pediatric Intestinal Failure: Nutrition, Pharmacologic, and Surgical Approaches Nutr Clin Pract, December 1, 2007; 22(6): 653 - 663. [Abstract] [Full Text] [PDF]

				C. Z. Michaylira, N. M. Ramocki, J. G. Simmons, C. K. Tanner, K. K. McNaughton, J. T. Woosley, C. J. Greenhalgh, and P. K. Lund Haplotype Insufficiency for Suppressor of Cytokine Signaling-2 Enhances Intestinal Growth and Promotes Polyp Formation in Growth Hormone-Transgenic Mice Endocrinology, April 1, 2006; 147(4): 1632 - 1641. [Abstract] [Full Text] [PDF]

				N. R. Parekh and E. Steiger Criteria for the Use of Recombinant Human Growth Hormone in Short Bowel Syndrome Nutr Clin Pract, October 1, 2005; 20(5): 503 - 508. [Abstract] [Full Text] [PDF]

				A R Weale, A G Edwards, M Bailey, and P A Lear Intestinal adaptation after massive intestinal resection Postgrad. Med. J., March 1, 2005; 81(953): 178 - 184. [Abstract] [Full Text] [PDF]

				Z. Weiming, L. Ning, and L. Jieshou Effect of Recombinant Human Growth Hormone and Enteral Nutrition on Short Bowel Syndrome JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 377 - 381. [Abstract] [Full Text] [PDF]

				N. E. Avissar, T. R. Ziegler, L. Toia, L. Gu, E. C. Ray, J. Berlanga-Acosta, and H. C. Sax ATB0/ASCT2 Expression in Residual Rabbit Bowel Is Decreased after Massive Enterectomy and Is Restored by Growth Hormone Treatment J. Nutr., September 1, 2004; 134(9): 2173 - 2177. [Abstract] [Full Text] [PDF]

				K. V. Haderslev, P. B. Jeppesen, H. A. Sorensen, P. B. Mortensen, and M. Staun Body composition measured by dual-energy X-ray absorptiometry in patients who have undergone small-intestinal resection Am. J. Clinical Nutrition, July 1, 2003; 78(1): 78 - 83. [Abstract] [Full Text] [PDF]

				J. S. Scolapio Short Bowel Syndrome JPEN J Parenter Enteral Nutr, September 1, 2002; 26(5_suppl): S11 - S16. [PDF]

				J S SCOLAPIO Effect of growth hormone and glutamine on the short bowel: five years later Gut, August 1, 2000; 47(2): 164 - 165. [Full Text] [PDF]